Here are five details:
1. The company reported $73.6 million in second quarter revenue, a 12 percent increase year-over-year.
2. K2M’s U.S. complex spine segment brought in $21.8 million in revenue, up 7 percent year-over-year.
3. Within the U.S. minimally invasive surgery segment, K2M reported $8.7 million in revenue, a 1 percent decrease year-over-year.
4. K2M experienced the most growth in its U.S. degenerative segment generating $23.8 million in the second quarter, a 10 percent uptick year-over-year.
5. International revenue for the quarter reached $19.3 million, a 29.1 percent year-over-year increase.
To view the full financial report, click here.
More articles on devices and implants:
DePuy Synthes, Medtronic, NuVasive & more: 9 device company notes
These 3 companies dominate the global hip & knee surgical implants market
Wearable devices, patient data & the future of specialty surgical care: 6 Qs with VivaLNK’s CEO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
